drugset / Trial / NCT02331771
Donepezil Memory Preservation Post ECT
RandomizedSingle-groupTriple-blindPrevention
Summary
This randomized, placebo-controlled trial will evaluate the use of donepezil compared to placebo to reduce the risk of memory impairment after electroconvulsive therapy (ECT).
Timeline
- Start
- 2015-09-24
- Primary completion
- 2017-01-25
- Completion
- 2017-03-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Donepezil | Small molecule | 5 mg | — |